Gamco Investors INC. ET AL cut its stake in Middlesex Water (NASDAQ:MSEX) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 63,953 shares of the utilities provider’s stock after selling 1,833 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Middlesex Water were worth $2,347,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of MSEX. Creative Planning increased its stake in shares of Middlesex Water by 23.1% in the fourth quarter. Creative Planning now owns 7,284 shares of the utilities provider’s stock worth $291,000 after acquiring an additional 1,369 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Middlesex Water in the fourth quarter worth $107,000. Stephens Inc. AR increased its stake in shares of Middlesex Water by 44.8% in the fourth quarter. Stephens Inc. AR now owns 13,673 shares of the utilities provider’s stock worth $546,000 after acquiring an additional 4,231 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Middlesex Water in the fourth quarter worth $222,000. Finally, Private Advisor Group LLC increased its stake in shares of Middlesex Water by 20.7% in the fourth quarter. Private Advisor Group LLC now owns 8,688 shares of the utilities provider’s stock worth $278,000 after acquiring an additional 1,488 shares during the last quarter. 51.91% of the stock is currently owned by institutional investors and hedge funds.
Top Low Price Stocks To Watch For 2021: Smith(ds)
DS Smith Plc, through its subsidiaries, engages in the supply of recycled packaging for consumer goods and the wholesale of office products worldwide. The company collects waste paper and old corrugated containers for the production of recycled paper; and manufactures corrugated packaging and board. It also offers returnable transit packaging products, including reusable container and pallet systems, extruded sheets, and bottle crates used in retail, automotive, electronics, and beverage sectors; and liquid packaging and dispensing products comprising bags and taps for bag-in-box packaging systems that are used in beverage sector, industrial solutions, and personal care products. The company was formerly known as David S. Smith (Holdings) PLC and changed its name to DS Smith Plc in 2001. DS Smith Plc was founded in 1940 and is headquartered in Maidenhead, the United Kingdom.
- [By Motley Fool Transcribers]
Drive Shack Inc. (NYSE:DS)Q42018 Earnings Conference CallMarch 14, 2019, 9:00 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Shane Hupp]
Get a free copy of the Zacks research report on Drive Shack (DS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Redwood Trust (NYSE: RWT) and Drive Shack (NYSE:DS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk.
Top Low Price Stocks To Watch For 2021: Argan, Inc.(AGX)
Argan, Inc., incorporated on May 15, 1961, is a holding company. The Company conducts operations through its subsidiaries, Gemma Power Systems, LLC and affiliates (GPS), Atlantic Projects Company Limited (APC), Southern Maryland Cable, Inc. (SMC) and The Roberts Company (Roberts or TRC). The Company’s segments include power industry services, industrial fabrication and field services, and telecommunications infrastructure services. Through GPS, the Company provides a range of engineering, procurement, construction, commissioning, operations management, maintenance, development and consulting services to the power generation and renewable energy markets for a range of customers, including independent power project owners, public utilities, municipalities, public institutions and private industry. Through APC, the Company provides construction and technical services for power generation, oil and gas, industrial and process industry customers. Through SMC, the Company provides telecommunications infrastructure services, including project management, construction and maintenance to commercial, federal Government and local Government customers. Through TRC, the Company provides fully integrated fabrication, construction and plant services designed to work with heavy and light industrial customers.
Power Industry Services
GPS and APC represent the Company’s power industry services segment. GPS is a service engineering, procurement and construction (EPC) contractor with the abilities of designing, building and commissioning energy projects. The Company’s power industry services business has projects for over 70 facilities representing over 14,000 megawatts (MW) of power-generating capacity. Its power projects have base-load combined-cycle facilities, simple-cycle peaking plants and boiler plant construction and renovation efforts. The Company also provides EPC contracting services to the owners of alternative energy facilities, including biomass plants, wind farms and solar fields. ! GPS is engaged in plant design and construction from site development through electrical interconnection and plant testing. APC provides turbine, boiler and large rotating equipment installation, commissioning and outage services to original equipment manufacturers, global construction firms and plant owners across the world. The Company has completed a biomass-fired project for East Texas Electric Cooperative, Inc. (ETEC) covering EPC contracting services for approximately 50 MW power plant fueled by chipped timber located near Woodville, Texas.
Industrial Fabrication and Field Services
TRC is an industrial fabricator and constructor serving both light and heavy industrial organizations primarily in the southern United States, including pulp and paper, petrochemical and power companies. Through Roberts, the industrial fabrication and field services segment produces, delivers and installs fabricated steel components specializing in pressure vessels and heat exchangers for industrial plants. In addition, Roberts includes a plant services group that handles maintenance turnarounds, shutdowns and emergency mobilizations.
Telecommunications Infrastructure Services
Through SMC, which represents the Company’s telecommunications infrastructure services business segment, it provides technology wiring and utility construction solutions to customers in the mid-Atlantic region. The Company performs both outside plant and inside plant cabling services. Services provided to its outside premises customers include trench-less directional boring and excavation for underground communication and power networks, aerial cabling services, and the installation of buried cable, high and low voltage electric lines, and private area outdoor lighting systems. The outside premises services are provided to state and local Government agencies, regional communications service providers, electric utilities and other commercial customers. The inside premises wiring services that Comp! any provi! des to the customers include the structuring, cabling, terminations and connectivity that provide the physical transport for high speed data, voice, video and security networks. These services are provided to federal Government facilities, including cleared facilities, on a direct and subcontract basis.
The Company competes with Bechtel Corporation, Fluor Corporation, SNC-Lavalin Group, Inc., Chicago Bridge & Iron Company N.V., Skanska AB and Kiewit Corporation.
- [By Logan Wallace]
Media stories about Argan (NYSE:AGX) have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Argan earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the construction company an impact score of 45.7492523122329 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Top Low Price Stocks To Watch For 2021: Kitov Pharamceuticals Holdings Ltd.(KTOV)
Kitov Holdings was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. Our ordinary shares are currently traded on the TASE under the symbol “KTOV”, and our ADSs and our public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively.
In October 2012, the District Court in Lod approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Holdings (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Holdings’ creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Holdings and its creditors. Advisors’ Opinion:
- [By Shane Hupp]
Ardelyx (NASDAQ: ARDX) and KITOV PHARMA LT/S (NASDAQ:KTOV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends.
- [By Lisa Levin] Gainers
TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Top Low Price Stocks To Watch For 2021: Celldex Therapeutics Inc(CLDX)
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. The company markets Rotarix to treat rotavirus infection. Its lead drug candidate, rindopepimut (CDX-110), is an immunotherapeutic vaccine in Phase III clinical trial to target the tumor-specific molecule, epidermal growth factor receptor variant III, as well as in Phase II clinical trial for the indication of recurrent glioblastoma. The company?s other lead drug candidates comprise CDX-011, an antibody-drug conjugate in Phase IIb clinical trial for metastatic breast cancer and melanoma indication; and CDX-1127, a human monoclonal antibody in Phase I clinical trial for the treatment of lymphoma/leukemia and solid tumors. Its additional clinical and preclinical programs consist of CDX-1401, an Antigen Presenting Cells Targeting Technology program in Phase I/II clinical trial to tr eat multiple solid tumors; and CDX-301, an immune cell mobilizing agent and dendritic cell growth factor in Phase I clinical for treating cancer, autoimmune disease, and transplant. The company?s preclinical products include CDX-1135, a molecule for treating renal disease; and CDX-014, a human monoclonal antibody-drug conjugate for the treatment of ovarian and renal cancer. It has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Alteris Therapeutics, Inc.; Thomas Jefferson University; 3M Company; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc. Celldex Therapeutics, Inc. was founded in 1983 and is headquartered in Needham, Massachusetts.
- [By Keith Speights]
Celldex Therapeutics (NASDAQ:CLDX) is in a much different place than it was one year ago. The biotech continues to feel the repercussions from the failure of glembatumumab vedotin (glemba) in the Metric clinical study targeting the treatment of triple-negative breast cancer.
- [By Motley Fool Transcription]
Celldex Therapeutics, Inc. (NASDAQ:CLDX)Q4 2018 Earnings Conference CallMarch 7, 2019, 4:30 p.m. ET
Prepared Remarks Questions and Answers Call Participants